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Introduction 
Calf deep vein thrombosis (DVT)stil l remains a 
debatable ntity in terms of its clinical importance and 
its management. Minimal, non-obstructive calf vein 
thrombi that are asymptomatic, are encountered up to 
30% in hospitalised or postoperative patients after 
surveillance investigation by radioactive fibrinogen 
leg scanning or venography. 1'2 It has been stated that 
calf deep vein thrombi become clinically important 
only when they extend into the proximal veins. 3 
However, untreated asymptomatic calf DVT might 
carry a 2% incidence of fatal pulmonary embolism 
(PE) in bedridden immobile patients, based on a 20% 
rate of propagation of calf thrombi. 4 Similarl~ it is 
debated whether untreated isolated calf thrombosis 
causes post-thrombotic syndrome unless proximal 
extension occurs. 5 Nevertheless, abnormal venous 
function has been reported after asymptomatic 6'7and 
symptomatic 8'9 calf DVT. It has been estimated that 
the risk of the post-thrombotic syndrome resulting 
from untreated asymptomatic calf DVT would be 
approximately 4%, based on a 202 rate of extension of 
calf thrombi. 4
Symptomatic calf DVTs are usually found in asso- 
ciation with thrombosis in the more proximal veins. 
The incidence of isolated symptomatic alf DVT is 
unclear, with reports suggesting rates varying from 9 
to 46%9 -13 However, the isolated symptomatic calf 
thrombi are probably larger than the asympto- 
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matic 13-15 and so are more likely to cause 
complications. 
The management of calf DVT is based on comparing 
its risk of early complications with the risk of 
anticoagulation. Bleeding complications, particularly 
in elderly and postoperative patients can be a source 
of significant morbidity and many would argue that 
such treatment is not justified when the risk of 
pulmonary embolism is low. The advent of sophisti- 
cated non-invasive techniques for diagnosing DVT, 
may now make it possible to be more selective in 
identifying those patients with calf DVT who should 
be treated. 
In this review, we wish to set out logical guidelines 
for the management of calf DVT, using non invasive 
imaging techniques, based on what is known about its 
natural history, complications, and treatment. 
Origin of Deep Venous Thrombosis 
The origin of DVT in the lower limb has been a subject 
of considerable controversy. It is now known that the 
vast majority of the thrombi commence in the deep 
16-19 calf veins I but it is apparent hat acute DVT can 
start anyqarhere in the venous system, including the 
proximal veins of the leg and pelvis.1, s-2~ However, it 
has been shown, with few exceptions, that whenever 
there are thrombi in the proximal veins, there are 
always thrombi present in the calf veins. ~°'1s'22-24 
The incidence of isolated symptomatic calf DVT is 
unclear. Philbrick and Becker, 26 in a review of 20 
studies including 2140 patients (medical and surgical) 
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where DVT was documented by venography, reported 
a 48.8% incidence of calf DVT. In two other studies ~°'11 
including 327 limbs with DVT detected by venog- 
raphy the incidence was 46%, and in another one 27 
including 24 patients with DVT detected by Duplex 
ultrasonography was 37.5%. Markel et al. 12 reported 
that isolated calf DVT was 9% in their series. 
The distribution of DVT it is said to be more or less 
similar in both the surgical and medical 
patients. 3'1°'23"24'28'29 Also, in another study the origin 
and the distribution of DVT in symptomatic ambula- 
tory patients was equivalent o that in inpatient 
population. 16 However, the majority of these studies 
included a mixed population (medical and surgical) 
and it is not completely clear whether the studied 
individuals were ambulant or immobile, inpatients or 
outpatients, and the kind of the operation or illness 
they experienced since there is no adequate descrip- 
tion on the patient demographic data. Therefore, it is 
apparent that, the true incidence of calf DVT in 
different groups and subgroups of patients is very 
difficult to be evaluated precisely. 
Natural History 
Thrombi in the calf veins either may lyse sponta- 
neousl~ or recanalise over several weeks or months. 
Alternativel~ they may stay localised to the calf or 
extend up to the proximal veins of the leg. Recurrence 
is also commonly seen. 
(A) Lysis and recanalisation of deep venous thrombi 
It is known that immediately after the occurrence of 
DVT collateral circulation develops to bypass the 
obstruction and to provide a fair venous outflow. 31 
Lysis of the thrombi can occur at any time, from some 
hours to months after the occurrence of the thrombo- 
sis. 3'32 Kakkar et al. 3 reported that in their series 
including postoperative patients one third of the acute 
thrombi lysed within 72 h and these thrombi obvi- 
ously would never be picked up by clinical assess- 
ment. Spontaneous lysis of the thrombi might be a 
result of the local fibrinolytic activity (plasminogen 
activator elease). 2s 
(B) Proximal extension of calf thrombi 
Proximal propagation of the thrombi can occur, and 
sometimes this may happen in a late period after the 
initial diagnosis of DVT. ~3 Browse and Thomas 2s have 
estimated in their series that two-thirds of the thigh 
and one-half of the pelvic thromboses were due to 
propagation of the calf DVT. The incidence of prox- 
imal extension of the calf thrombi in postoperative 
patients varies from 5.6% to  30% 3'26'30"34"35 with a 10% 
propagation rate in symptomatic patients. 9 Asympto- 
matic calf vein thrombi, detected by radioactive 
fibrinogen leg scanning, extended into the proximal 
veins in 20% of cases. 3In another stud~ 36 75 medical 
and surgical patients, with isolated calf vein thrombi 
were prospectively monitored with sequential Duplex 
scans at 3- to 4-day intevals, 24 of the patients (34%) 
had a thrombus propagation i to the proximal veins. 
In this stud~ sex, age, obesit~ trauma, estrogen use, 
malignanc~ varicose veins, smoking, surger~ and 
activity level were not predictive of propagation. 
However, it is still not known whether factors such as 
blood transfusion, the type and duration of surgery or 
anesthesia may interfere to calf vein thrombi 
propagation. 
The pattern of thrombus propagation still remains 
unresolved. From necropsy studies 2°'21"3B we know 
that thrombosis may be present at different sites in the 
venous tree of the lower limb with evidence that 
propagation can occur in either a proximal or distal 
direction. Other clinical studies have shown that the 
vast majority of thrombi commence in the calf veins 
and extend proximally by forming a continuous 
1 28 37--41 column of thrombus. ' ' Todaj6 the pattern of 
antegrade proximal extension of the calf thrombi is 
well established and widely accepted. 
Prophylaxis with low doses of heparin significantly 
reduces both the incidence and the proximal extension 
of the DVT. In a review of four large studies 3s'42~4 
including 3116 patients undergoing elective abdomi- 
nal operations, 95 (6.4%) out of 1485 patients in 
heparin group had thrombosis, and proximal exten- 
sion occurred only in nine (0.6%) patients. On the 
other hang in the control group 380 of 1631 (23.3%) 
patients had calf DVT and proximal extension 
occurred in 99 (6%) patients. This finding is supported 
in a study of 78 patients undergoing total hip or knee 
arthroplasty, where Barnes et al. 4s reported proximal 
extension of isolated calf DVT in 18% of patients who 
did not receive anticoagulation. In another study 27 
evaluating 24 patients with acute DVT using Duplex 
ultrasonography, nine patients (37.5%) had thrombo- 
sis confined to the calf veins and four had progression 
of thrombosis at the proximal veins despite being on 
anticoagulant treatment. There was no difference in 
the anticoagulation level between propagators and 
non-propagators and of the demographic and clLrfical 
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variables examined, only smoking correlated with 
progression of thrombus. These results raise quite 
interesting questions. 46Will some patients with DVT 
have proximal extension of the thrombi regardless of 
their adequate anticoagulation level with heparin as 
other studies have shown on venography that up to 
20% of patients with DVT will experience deteriora- 
tion receiving heparin. 47 The ideal amount of heparin 
given to patients with DVT should be the lowest dose 
that prevents the proximal extension of thrombosis. 4s
However, this dose has not yet been established. Also, 
there is no information in the existing literature 
regarding the factors that could identify the high risk 
patient in whom extension of thrombosis in to 
proximal veins from the calf could be anticipated. 
(C) Recurrence of deep venous thrombosis 
A previous history of thrombosis is one of the major 
predisposing factors for recurrent DVT in both ambu- 
lant and bedridden patients, 17'49'5° and the calf veins 
are the most frequently affected. Rollins et al. 51 
reported that all limbs with recurrent acute DVT had 
evidence of previous calf thrombi, and only 13% had 
previous proximal disease. In another stud~ 18 54 of 
the 80 limbs (67.5%) with DVT had evidence of a 
recurrence involving the calf veins and/or the prox- 
imal veins. In patients with symptomatic calf DVT, a 
29% rate of recurrence has been reported without 
adequate anticoagulant treatment. 52This recurrence 
was prevented in 96% with orally given anticoagulant 
treatment for 3 months, s3 
(D) Pulmonary embolism from calf thrombi 
The concept hat calf vein thrombi are asymptomatic 
and clinically unimportant and that only when they 
extend to the proximal veins can lead to PE, has been 
a general impression held by many clinicians. Kakkar 
et al. 3 reported 10% incidence of PE in postoperative 
patients with asymptomatic calf DVT detected by 
radioactive fibrinogen leg scanning but in these cases 
the calf vein thrombi had extended into the proximal 
veins before the PE become obvious. However, in a 
comprehensive r view of the literature, it was pointed 
out that DVT confined to the calf alone is not always a 
benign condition, and incidence of PE as high as 29% 
have been related including two fatal events. 26 Mor- 
eno-Cabral et al. 41 examined 54 patients with positive 
venograms howing DVT either in the calf and/or 
popliteal veins. In these series, popliteal and calf 
thrombi had a 66% and 33% incidence of PE respec- 
tively, identified by changing V-Q imbalance on serial 
scans, or positive pulmonary angiogram. These find- 
ings support the impression that thrombi become 
more dangerous when they extend into the popliteal 
vein. Nevertheless, the incidence of PE associated with 
calf DVT was relatively high and not be ignored, 
although most of the emboli arising from the calf veins 
in these series were silent. Browse and Lea-Thomas 2s 
have reported that in a series of 201 patients with PE 
in 53 (26%) the source of the emboli were the calf 
veins. Barnes et al. 45 reported that, isolated calf 
thrombi accounted for the only two cases of PE in their 
series of 78 patients with perioperative asymptomatic 
DVT. In two other studies, 36"52 the rate of fatal PE 
arising from the deep calf veins was 15% and 13% 
respectively. Indeed, Dorfman et al. 54 performed ven- 
tilation-perfusion scans in 58 patients with veno- 
graphically proven DVT in a prospective study to 
determine the prevalence of occult PE. They found 
that all nine patients with below-knee DVT alone had 
low-probability abnormal scans, while of the other 49 
with above-knee DVT, 12 had normal scans, 17 had 
low-probability scans, three had moderate or unde- 
termined scans, and 17 had high-probability scans. 
Therefore, it is apparent that calf deep vein thrombi 
do cause PE. However, in the majority of the reported 
cases, the PE was not associated with any clinical 
signs, and was only detected by lung scans. 
It is very important o take into account hat many 
of the reported cases with calf deep vein thrombi are 
asymptomatic and detected by radioactive fibrinogen 
leg scannings performed as surveillance for research 
purposes and otherwise these could have been 
missed. Also, it is fairly logical to say that many of the 
reported PEs due to calf DVT could not have been 
picked up without a lung scan and obviously their 
clinical significance is unknown. An additional point 
should be made in regard to the method that was 
being used in the majority of studies in the diagnosis 
of PE. It is known that accurate diagnosis can be made 
only by pulmonary angiography. Lung scan can 
overdiagnose PEs and this might account for a falsely 
increased incidence of PE in many studies. Therefore, 
it is very difficult to estimate precisely the prevalence 
of PE from thrombi confined to the calf deep veins 
alone. Furthermore, in many studies it is not known 
whether proximal propagation of the calf thrombi had 
occurred before the onset of the PE in patients with 
previously venographically diagnosed calf DVT. The 
impression that the majority of thrombi confined to 
deep veins in the calf are clinically unimportant even 
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if they cause asymptomatic PE, still remains. Sympto- 
matic calf thrombi, that are larger and tend to extend 
into the proximal veins, are more likely to be the 
hazardous ones causing clinically important pulmo- 
nary embolism. 4 Thus, it would appear that if we can 
identify early those by symptomatic thrombi with 
high probability to propagate proximally early antico- 
agulant reatment should be instituted. 
(E) Post-thrombotic sequela of calf deep vein thrombosis 
Once again, there is a common belief that small calf 
deep vein thrombi do not precipitate post-thrombotic 
syndrome unless they extend into the proximal veins. 
It is anticipated that the risk of the post-thrombotic 
syndrome resulting from untreated asymptomatic calf 
DVT would be approximately 4%, if one allows for a 
20% rate of extension of calf thrombi. 4 However, 
Lindhagen et al. 5s reported that long-term post- 
thrombotic syndrome after calf DVT occurs as often as 
it occurs after more proximal DVT. Browse and 
Clemenson 7 reported that of 61 patients who had calf 
deep vein thrombi detected by leg scanning associated 
with mild calf symptoms, 21% had persistent pain and 
23% persistent swelling 3--4 years later, but leg 
symptoms were also similar in patients with negative 
leg scans. Browse et al. s suggested a 20% incidence of 
moderate to serious post-thrombotic syndrome 5-10 
years after symptomatic alf DVT. However, this 
evaluation was made only on the basis of clinical 
assessment alone and did not include any haemody- 
namic measurements. Five years later, Kakkar and 
Lawrence 9 reported 38% mild to moderate and 15% 
severe haemodynamic changes 6 months after calf 
DVT using foot volumetry. These abnormalities 
remained almost unchanged at 2 years. Since then 
many other authors have also confirmed that long 
term symptoms and haemodynamic changes are 
significant complications after calf DVT. 5'6'56 
Diagnosis of Calf Deep Vein Thrombosis 
The clinical diagnosis of DVT in symptomatic patients 
has been shown to be inaccurate in approximately 50% 
of cases 15"57-59 but the diagnosis of DVT is of para- 
mount importance before treating the patients. 
Ascending venography is still considered the "gold 
standard" investigation i the diagnosis of DVT. 6°-63 
However, this is an invasive technique, exposes the 
patient to radiation and allergic reactions, causes 
discomfort, cannot be frequently repeated, and cannot 
be performed in pregnant women and where there is 
difficulty in gaining venous access in the foot. 
Non-invasive diagnostic modalities that cause less 
inconvenience to the patients, have been used in the 
last decade. Gray-scale Duplex imaging and ascend- 
ing venography were evaluated in a review of 25 
studies, 62 including 2781 symptomatic patients. The 
sensitivity of the Duplex for proximal DVT was 96% 
while for calf DVT was 80%. Lensing et al. 65 showed 
that the sensitivity of real-time B-mode duplex imag- 
ing for isolated calf vein thrombosis was only 36%. 
This has been confirmed in another two studies 66'67 
comparing Duplex and venography in47 and 68 limbs 
with suspected DVT respectively. Thus it would 
appear that Duplex imaging might challenge the 
ascending venography in the diagnosis of proximal 
DVT. However, it may miss more than 20% of isolated 
calf thrombi. 64 
Colour flow Duplex imaging (CFDI) has now 
emerged as a new more accurate modality in the 
diagnosis of calf DVT. 68'69 This technique has 
improved the diagnostic accuracy of isolated calf DVT 
in symptomatic patients to a 86% sensitivity and 91% 
specificity. 7°Recentl)~ Bradley et aI. 71 reported 100% 
sensitivity and specificity for isolated calf DVT in their 
series in symptomatic patients. CFDI is now challeng- 
ing venography as the "gold-standard" investigation 
for the diagnosis of DVT even in the calf veins. 69 
However, the CFDI is not an accurate xamination for 
detection of acute calf DVT in asymptomatic post- 
operative patients. Rose et al. 72 reported 42% sensitiv- 
ity of CFDI for acute asymptomatic calf thrombi n 
postoperative patients. 
Postoperative asymptomatic alf DVT can be 
detected by 125I-labelled fibrinogen uptake test 
(FUT) 1"3 and impedance plethysmography (IPG). 73'74 
In 1970's these techniques were accepted enthusias- 
tically as an accurate screening test. Although these 
methods are considered to be objective their inter- 
pretation is in part subjective and as much has serious 
limitations. 75 Therefore, at present venography still 
remains the only proven accurate method for the 
detection of asymptomatic DVT in high risk 
patients. 7s 
Magnetic resonance imaging (MRI) also has been 
used in the diagnosis of calf DVT in suspected patients 
with comparable r sults with ascending venography 76 
emerging as another investigation that possibly could 
replace venography for diagnosis of calf DVT. 
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Does Calf Deep Vein Thrombosis Require 
Treatment? 
The use of CFDI that can challenge venography in 
diagnosis and follow-up of calf vein thrombi can offer 
alternative therapeutic approaches in the management 
of this problematic area. 
There is no agreement on the need to treat calf DVT, 
especially in asymptomatic cases detected by labeled 
fibrinogen scanning since these thrombi are con- 
sidered to be small in size and associated with lower 
incidence of pulmonary embolism. 77 However, 
untreated small calf deep vein thrombi that are 
detected by labeled fibrinogen scanning might cause 
fatal pulmonary embolism in 2% of bedridden 
patients and post-thrombotic syndrome in 4%. 4 It has 
been recommended that only patients with a labeled 
fibrinogen scanning in the calf persistently positive for 
more than 48 h receive anticoagulant treatment. 7s 
Hirsh and Gallus (personal communication) sug- 
gested anticoagulant treatment only in the cases that 
repeated fibrinogen scan indicates proximal extension 
of the calf deep vein thrombi. 77 So far there is no 
available data showing the superiority of this 
approach on treating all patients with calf DVT with 
anticoagulant treatment. 
Moreno-Cabral et al. 41 recommended another 
approach in the management of calf DVT. They 
advocated treatment with heparin only when the calf 
thrombi are symptomatic n the legs or when they 
cause PE, silent of symptomatic. Also, in another 
study 52 the validity of the anticoagulant treatment 
(initial course of heparin, warfarin, and compression 
stockings) in calf DVT vs. no anticoagulant treatment 
(initial course of heparin, and compression stockings) 
was studied. They found statistical significant recur- 
rence rate of thrombosis with proximal extension in 
the non-treatment group of patients uggesting that 
oral anticoagulants should be given for 3 months to all 
patients with symptomatic calf deep vein thrombi. 
Lohr et al. 36 reported that calf vein thrombi are 
associated with a 32% incidence of propagation i to 
the proximal veins and a 5% incidence of high 
probability ventilation perfusion scans. Therefore, 
they suggested that all calf vein thrombi should be 
treated with anticoagulation since the risk of bleeding 
is only 4-10%. Also, they suggested no treatment 
combined with surveillance by repeat Duplex scan- 
ning only in those patients at high risk for anti- 
coagulation. In a review of the literature, 26the follow- 
up of the patients with calf DVT by serial IPG and 
delaying therapy with anticoagulants until propaga- 
tion has been shown to have occurred, has been 
supported as it was not clear that calf thrombi had 
leaded to complications unless they had extended to 
the proximal veins. Solis et al. 79 recently reported that 
in patients who underwent total joint arthroplasties of 
the lower extremities, propagation of asymptomatic 
calf DVT was not influenced by anticoagulation, 
suggesting that these thrombi should not be routinely 
treated. Also, they advocated that surveillance by 
serial Duplex scanning is a useful tactic and anti- 
coagulation should be given only in case of thrombus 
propagation. The same management of calf DVT is 
advocated also by Barnes, 8° reserving the anticoagu- 
lant treatment only for symptomatic patients, for those 
with evidence of extension of calf thrombi nto the 
proximal veins, and when clinical PE develops during 
follow-up. In Table 1 the outcome of calf deep vein 
thrombosis with or without reatment is displayed. As 
it is seen in this table, there is no significant difference 
in the incidence of proximal propagation of the calf 
thrombi and PE between treated and untreated 
patients. However, no conclusion can be emerged 
because these studies were not randomised and 
prospective and included different patients and treat- 
ment protocols each other. Indeed, so far there are not 
well controlled randomised prospective trials using 
screening tests or CFDI in patients with thrombi 
confined to calf veins in order to evaluate the 
incidence of complications (e.g. PE) and the long term 
outcome (e.g. post-thrombotic sequela) with different 
therapeutical pproaches. 
Nowadays, two approaches eem to be accepted 
giving a reasonable management in the patients with 
calf DVT. Heparin and warfarin started at the same 
time, with heparin discontinued after 4 days and less- 
Table 1. Outcome of calf deep vein thrombosis with or without 
treatment 
No 
patients/ Proximal 
Author Year limbs* propagation PE 
No anticoagulation 
Kakkar et al. 3 1969 39 9 (23%) 4 (10%) 
Doouss et al. 3° 1976 124 7 (5.6%) 2 (1.6) 
Hull et al. 83 1981 11 0 0 
Moser, LeMoine 84 1981 21 0 0 
Lohr et al.36 1991 75 11 (15%) 4 (5%) 
Softs et ai.79 1992 21 2 (9.5%) 0 
Barnes80 1993 25* 2 (8%) 0 
Anticoagulation 
Hull et al.85 1979 32 0 0 
Bentley et al.86 1980 100 1 (1%) 2 (2%) 
Menzoian et al31 1983 107 Not studied 4 (3.7%) 
Lagerstedt etal.53 1985 51 Not studied I (2%) 
Kakkar, Lawrence 9 1985 98 10 (10%) Not studied 
Schulman et al. 87 1986 36 0 Not studied 
Krupski et al. 27 1990 9 4 (44.4%) 0 
Softs et al. 79 1992 11 3 (27.3%) 0 
Barnes 8° 1993 13" 3 (23%) 0 
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intense warfarin (international normalised ratio 
INR = 2.0-3.0) continued for 6 weeks. 21"s2 As a reason- 
able alternative to anticoagulant treatment is con- 
sidered the surveillance with IPG 4'73"74 or CFDI 4'79'8° 
for 7-10 days (or longer if the patients remains 
immobile) and treatment only when there is evidence 
of thrombus propagation. The latter tactic seems much 
more reasonable in asymptomatic patients, when the 
calf thrombus is single and small. 
Nevertheless, the management of isolated calf DVT 
still remains controversial. The efficacy of the pro- 
posed tactics for treatment of calf DVT in terms of 
decrease of the incidence of PE, the recurrence rate, 
and the long-term post-thrombotic sequela should be 
evaluated by well randomised prospective trials. 
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